SAPUPPO, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 1.353
EU - Europa 982
AS - Asia 865
AF - Africa 114
SA - Sud America 103
OC - Oceania 1
Totale 3.418
Nazione #
US - Stati Uniti d'America 1.320
SG - Singapore 369
IT - Italia 368
RU - Federazione Russa 317
CN - Cina 277
BR - Brasile 79
KR - Corea 77
VN - Vietnam 70
CI - Costa d'Avorio 65
NL - Olanda 45
FR - Francia 40
IE - Irlanda 36
DE - Germania 29
GB - Regno Unito 28
SE - Svezia 28
CA - Canada 23
NG - Nigeria 20
IN - India 19
FI - Finlandia 17
AR - Argentina 10
BD - Bangladesh 10
PL - Polonia 10
BJ - Benin 9
CZ - Repubblica Ceca 9
ES - Italia 9
JP - Giappone 8
MX - Messico 8
UA - Ucraina 8
SN - Senegal 7
AL - Albania 6
LT - Lituania 6
ZA - Sudafrica 6
HK - Hong Kong 5
IQ - Iraq 5
CL - Cile 4
MD - Moldavia 4
MY - Malesia 4
BE - Belgio 3
CO - Colombia 3
ID - Indonesia 3
PK - Pakistan 3
PY - Paraguay 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BG - Bulgaria 2
BY - Bielorussia 2
EC - Ecuador 2
GA - Gabon 2
GR - Grecia 2
KG - Kirghizistan 2
MT - Malta 2
RS - Serbia 2
SI - Slovenia 2
TN - Tunisia 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
AZ - Azerbaigian 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
IR - Iran 1
MA - Marocco 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 3.418
Città #
Dallas 259
Singapore 259
Houston 172
Moscow 151
Santa Clara 151
San Jose 149
Hefei 120
Chandler 81
Seoul 77
Chicago 70
Abidjan 65
Ashburn 56
Los Angeles 51
Beijing 39
Dublin 36
Civitanova Marche 35
Rome 31
Catania 28
Boardman 26
Lauterbourg 23
Buffalo 20
New York 18
Ho Chi Minh City 17
Montreal 15
Amsterdam 14
Milan 14
Council Bluffs 12
Hanoi 11
Palermo 11
São Paulo 11
Abuja 10
Grafing 10
Lagos 10
Naples 10
Cotonou 9
Andover 8
Cambridge 8
Lappeenranta 8
Lawrence 8
Marseille 8
Munich 8
Orem 8
Tokyo 8
Warsaw 8
Bari 7
Brooklyn 7
Chennai 7
Columbus 7
Dakar 7
Nanjing 7
Aci Castello 6
Boston 6
Brno 6
London 6
Toronto 6
Bremen 5
Caserta 5
Charlotte 5
Da Nang 5
Genoa 5
Haiphong 5
Hong Kong 5
Johannesburg 5
Misterbianco 5
Padova 5
Poplar 5
Stockholm 5
The Dalles 5
Atlanta 4
City of London 4
Denver 4
Florence 4
Frankfurt am Main 4
Helsinki 4
Jacksonville 4
Kochi 4
Modena 4
Reggio Emilia 4
Rio de Janeiro 4
Rose 4
San Francisco 4
Turku 4
Valledolmo 4
Wilmington 4
Bologna 3
Brussels 3
Can Tho 3
Des Moines 3
Guangzhou 3
Hebei 3
Kyiv 3
Madrid 3
Paris 3
Phoenix 3
Querétaro 3
Ragusa 3
Saint Petersburg 3
Tirana 3
Turin 3
Vĩnh Long 3
Totale 2.392
Nome #
Time to Separate Persistent from Recurrent Differentiated Thyroid Cancer: Different Conditions with Different Outcomes 290
Valore predittivo di recidiva/persistenza di malattia della VII e VIII edizione del sistema di stadiazione TNM e del sistema di stratificazione del rischio (2015 e 2009) dell'American Thyroid Association in una serie prospettica consecutiva di 451 pazienti con carcinoma differenziato tiroideo. Proposta di un nomogramma predittivo di recidiva o persistenza di malattia 264
Role of gender on adverse events in a consecutive series of 28 patients with advanced differentiated thyroid cancer receiving lenvatinib 220
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 165
Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors 152
L’ipertiroidismo è un fattore di rischio di trombosi venosa e arteriosa: descrizione di un caso clinico 143
Risk of benign and malignant thyroid disorders in subjects treated for paediatric/adolescent neoplasia: Role of morphological and functional screening 138
Lymph node location is a risk factor for papillary thyroid cancer-related death 137
Persistenza vs Recidiva di malattia nel Carcinoma Differenziato della Tiroide 134
Orbital metastasis from thyroid cancer: a case report and review of the literature 131
Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome 123
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients 118
Is multifocality a risk factor in low-risk papillary thyroid cancer? 111
Evidenza RMN di metastasi orbitaria da carcinoma papillifero tiroideo avanzato: rara osservazione successiva a remota chemio- e radioterapia per Linfoma non Hodgkin 108
Farmaci innovativi per il trattamento del carcinoma tiroideo avanzato 104
Prognostic factors for adrenocortical carcinoma outcomes 103
Giant parathyroid adenoma: a rare cause of primary hyperparathyroidism mimicking a carcinoma 103
Familial non-medullary thyroid cancer represents an independent risk factor for increased cancer aggressiveness: A retrospective analysis of 74 families 102
Response to Letter to the Editor: "Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes" 101
Role of gender on adverse events in a consecutive series of 28 patients with advanced differentiated thyroid cancer receiving lenvatinib 98
Ruolo della 18FDG PET nel follow-up del carcinoma differenziato della tiroide (CDT) in presenza di valori di Tireoglobulina (Tg) indosabili, AAT elevati e TBS post-131-I negativo: esperienza clinica in una paziente 96
Recurrent parathyromatosis in a patient with concomitant MEN1 and CASR gene alterations: Clinical management of a case report and literature review 96
Gestione del carcinoma tiroideo in età pediatrica [Management of thyroid carcinoma in the paediatric age] 95
Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM 93
Therapeutic Efficacy of a Very Low/Low Dose of Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer: A Real-World Series from a Single Center 85
The new AJCC/TNM Staging System (VIII ed.) in papillary thyroid cancer: clinical and molecular impact on overall and recurrence free survival 83
Gender Impact on Safety and Efficacy in Lenvatinib treated patients with radioiodine-refractory Differentiated Thyroid Cancer (GISEL study) 60
Totale 3.453
Categoria #
all - tutte 9.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202246 1 7 0 3 8 0 8 2 3 0 1 13
2022/2023191 9 12 3 35 12 25 5 36 40 0 5 9
2023/2024187 14 20 2 3 2 53 0 18 0 2 19 54
2024/2025766 15 100 57 59 120 99 34 34 28 66 73 81
2025/20262.032 138 205 331 145 259 419 194 44 162 103 32 0
Totale 3.453